Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas

Oral Oncology

Volumn 45, Issue 10, 2009, Pages

  Silva, Sabrina Daniela da ^a,b   Cunha, Isabela Werneck ^b   Nishimoto, Inês Nobuko ^b   Soares, Fernando Augusto ^b   Carraro, Dirce Maria ^b   Kowalski, Luiz Paulo ^b   Graner, Edgard ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

ErbB2; Fatty acid synthase; Oral squamous cell carcinoma; USP2a

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FATTY ACID SYNTHASE; KI 67 ANTIGEN; MESSENGER RNA; UBIQUITIN; UBIQUITIN SPECIFIC PROTEASE 2A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CELL DIFFERENTIATION; CELL MEMBRANE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; ORAL SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PERINEURIUM; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CARCINOMA, SQUAMOUS CELL; ENDOPEPTIDASES; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GENE EXPRESSION; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PROGNOSIS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 70349145883     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.02.004     Document Type: Article

References (43)

1. Baron A., Migita T., Tang D., and Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer?. J Cell Biochem 91 1 (2004) 47-53
2. Jayakumar A., Tai M.H., Huang W.Y., al-Feel W., Hsu M., Abu-Elheiga L., Chirala S.S., and Wakil S.J. Human fatty acid synthase: properties and molecular cloning. Proc Natl Acad Sci USA 92 19 (1995) 8695-8699
3. Witkiewicz A.K., Nguyen K.H., Dasgupta A., Kennedy E.P., Yeo C.J., Lisanti M.P., and Brody J.R. Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome. Cell Cycle 7 19 (2008) 3021-3025
4. Ogino S, Nosho K, Meyerhardt JA, Kirkner GJ, Chan AT, Kawasaki T, et al. Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer. J Clin Oncol 2008;26(35):5713-20.
5. Horiguchi A., Asano T., Asano T., Ito K., Sumitomo M., and Hayakawa M. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol 180 3 (2008) 1137-1140
6. Notarnicola M., Altomare D.F., Calvani M., Orlando A., Bifulco M., D'Attoma B., et al. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. Oncology 71 5-6 (2006) 327-332
7. Kawamura T., Kanno R., Fujii H., and Suzuki T. Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma. Pathobiology 72 5 (2005) 233-240
8. Innocenzi D., Alo P.L., Balzani A., Sebastiani V., Silipo V., La Torre G., et al. Fatty acid synthase expression in melanoma. J Cutan Pathol 30 1 (2003) 23-28
9. Takahiro T., Shinichi K., and Toshimitsu S. Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin Cancer Res 9 6 (2003) 2204-2212
10. Kusakabe T., Nashimoto A., Honma K., and Suzuki T. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 40 1 (2002) 71-79
11. Alo P.L., Visca P., Framarino M.L., Botti C., Monaco S., Sebastiani V., et al. Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 7 6 (2000) 1383-1388
12. Silva S.D., Cunha I.W., Rangel A.L., Jorge J., Zecchin K.G., Agostini M., et al. Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes. Virchows Arch 453 1 (2008) 57-67
13. Silva S.D., Perez D.E., Alves F.A., Nishimoto I.N., Pinto C.A., Kowalski L.P., et al. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes. Oral Oncol 44 5 (2008) 484-490
14. Silva S.D., Perez D.E., Nishimoto I.N., Alves F.A., Pinto C.A., Kowalski L.P., et al. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings. Oral Dis 14 4 (2008) 376-382
15. Silva S.D., Agostini M., Nishimoto I.N., Coletta R.D., Alves F.A., Lopes M.A., et al. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. Oral Oncol 40 7 (2004) 688-696
16. Agostini M., Silva S.D., Zecchin K.G., Coletta R.D., Jorge J., Loda M., et al. Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells. Oral Oncol 40 7 (2004) 728-735
17. Krontiras H., Roye G.D., Beenken S.E., Myers R.B., Mayo M.S., Peters G.E., et al. Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue. Head Neck 21 4 (1999) 325-329
18. Sebastiani V., Visca P., Botti C., Santeusanio G., Galati G.M., Piccini V., et al. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. Gynecol Oncol 92 1 (2004) 101-105
19. Visca P., Sebastiani V., Pizer E.S., Botti C., De Carli P., Filippi S., et al. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma. Anticancer Res 23 1A (2003) 335-339
20. Alo P.L., Visca P., Trombetta G., Mangoni A., Lenti L., Monaco S., et al. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 85 1 (1999) 35-40
21. Gansler T.S., Hardman III W., Hunt D.A., Schaffel S., and Hennigar R.A. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28 6 (1997) 686-692
22. Alo P.L., Visca P., Marci A., Mangoni A., Botti C., and Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77 3 (1996) 474-482
23. Shurbaji M.S., Kalbfleisch J.H., and Thurmond T.S. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 27 9 (1996) 917-921
24. Menendez J.A., Lupu R., and Colomer R. Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer. Drug News Perspect 18 6 (2005) 375-385
25. Menendez J.A., Vellon L., Mehmi I., Oza B.P., Ropero S., Colomer R., et al. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci USA 101 29 (2004) 10715-10720
26. Menendez J.A., Mehmi I., Verma V.A., Teng P.K., and Lupu R. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Mol Carcinog 41 3 (2004) 164-178
27. Kumar-Sinha C., Ignatoski K.W., Lippman M.E., Ethier S.P., and Chinnaiyan A.M. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63 1 (2003) 132-139
28. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 79 1 (1994) 13-21
29. Ciechanover A., Orian A., and Schwartz A.L. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem Suppl 34 (2000) 40-51
30. Hershko A., and Ciechanover A. The ubiquitin system. Annu Rev Biochem. 67 (1998) 425-479
31. Chung C.H., and Baek S.H. Deubiquitinating enzymes: their diversity and emerging roles. Biochem Biophys Res Commun 266 3 (1999) 633-640
32. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J 11 14 (1997) 1245-1256
33. Graner E., Tang D., Rossi S., Baron A., Migita T., Weinstein L.J., et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5 3 (2004) 253-261
34. Gomes L.I., Silva R.L., Stolf B.S., Cristo E.B., Hirata R., Soares F.A., et al. Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray. Anal Biochem 321 (2003) 244-251
35. Saraiva T.F., Castro N.P., Pineda P.H.B., Osório C.A.B.T., Camargo L.P., Brentani H.P., et al. Effects of Oligo dT-T7 RNA primer in RNA amplification from paraffin-embedded tissue for microarray experiments. Appl Cancer Res 26 1 (2006) 14-20
36. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 7 (2002) RESEARCH0034
37. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 9 (2001) e45
38. Zhou X., Temam S., Oh M., Pungpravat N., Huang B.L., Mao L., et al. Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 8 11 (2006) 925-932
39. Wang E., Miller L.D., Ohnmacht G.A., Liu E.T., and Marincola F.M. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 18 4 (2000) 457-459
40. Xia W., Lau Y.K., Zhang H.Z., Xiao F.Y., Johnston D.A., Liu A.R., et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5 12 (1999) 4164-4174
41. Xia W., Lau Y.K., Zhang H.Z., Liu A.R., Li L., Kiyokawa N., et al. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 3 1 (1997) 3-9
42. Kim J.H., Park K.C., Chung S.S., Bang O., and Chung C.H. Deubiquitinating enzymes as cellular regulators. J Biochem 134 1 (2003) 9-18
43. Wing S.S. Deubiquitinating enzymes-the importance of driving in reverse along the ubiquitin-proteasome pathway. Int J Biochem Cell Biol 35 5 (2003) 590-605